MDAI eps in a glimpse
Analyst Rating Consensus
2
Ratings
MDAI Price Target
Highest Price Target
$3.50
138.1% Upside
)Mean Price Target
$3.50
138.1% Upside
)Lowest Price Target
$3.50
138.1% Upside
)MDAI Price Target History
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
MDAI Earnings History
After EPS - Where did the stock go?
Frequently Asked Questions
Brokerage firms have given MDAI stock an average recommendation of Buy. 2 analysts have given their ratings to MDAI out of which 0 analysts have given strong buy call, 2 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $3.50 gives the stock implied upside of roughly 138.1% over the next year or so.
Analysts suggest MDAI's stock price would rise to a high of $3.50.
Within the next 12 months, analysts predict the MDAI stock price could move to $3.50.
MDAI stock has an average analyst estimate of $3.50.
MDAI shares are currently trading 138.1% above this price target.
Its quarterly earnings per share (EPS) came in at -$0.16 versus consensus estimates of -$0.14, and below the comparable year-ago quarter’s EPS of -.
MDAI's forecasts by analysts estimating quarterly EPS at -$0.16 and - for the whole year.
The analysts have projected N/A EPS growth for MDAI in the next five years, compared to growth rates of N/A in the past five years.